Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study

Inclusion Criteria:

• Patients with mild-moderate Obstructive Sleep Apnea and snoring.

• Diagnosis of mild to moderate obstructive sleep apnea with Apnea Hypopnea Index 5-29events/hour confirmed within last 2 years with an in-lab diagnostic polysomnographyor home sleep apnea test.

• Ownership of a smartphone and willingness to use a smartphone application toautomatic log daily water intake.

• Willingness and ability to discontinue the currently prescribed OSA treatment for atleast 3 days prior to testing.

• Age greater than or equal to 18 years

Exclusion Criteria:

• Individuals not diagnosed with Obstructive Sleep Apnea and snoring.

• Significant weight change (10% change in body weight in Kg) from the time of the OSAdiagnosis until the study initiation.

• Persistent excessive daytime sleepiness (Epworth Sleepiness scale > 10), despitetreatment of OSA

• Significant medical comorbidities requiring restricted oral fluid intake -decompensated heart failure, end stage renal disease, end stage liver disease,hyponatremia (S. Na <130 mg/dl), nocturia > times/night.

• Unable or unwilling to participate in study procedures.

• Previous upper airway surgeries significantly modifying upper airway anatomy such asUPPP, apnea surgeries, oral and throat cancer surgeries or radiation.

• Known congenital or acquired diseases significantly affecting upper airway anatomysuch as Down's Syndrome, oral and throat cancer.

• BMI >40 kg/m^2.

• Currently treating OSA with hypoglossal nerve stimulator.